Advertisement

Carbohydrate antigen 15-3

  • S. HoldenriederEmail author
  • P. Stieber
Chapter
Part of the Springer Reference Medizin book series (SRM)

Literatur

  1. Duffy MJ (2017) Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM. Eur J Cancer 75:284–298CrossRefPubMedPubMedCentralGoogle Scholar
  2. Lamerz R (2012) CA 15-3. In: Thomas L (Hrsg) Labor und Diagnose, 8. Aufl. TH-Books, Frankfurt am Main, S 1644–1648Google Scholar
  3. Stieber P et al (2015) Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer-A retrospective analysis of kinetics on 743 breast cancer patients. Clin Chim Acta 448:228–231CrossRefPubMedPubMedCentralGoogle Scholar
  4. Sturgeon CM, Duffy MJ, Stenman UH et al (2008) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54:e11–e79CrossRefGoogle Scholar
  5. Trapé J et al (2011) Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med 49:1605–1620CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Institut für LaboratoriumsmedizinDeutsches Herzzentrum München, Klinik an der Technischen Universität MünchenMünchenDeutschland
  2. 2.Institut für LaboratoriumsmedizinKlinikum der Universität München (LMU)MünchenDeutschland

Personalised recommendations